標(biāo)題: Titlebook: Multi-Treatment Modalities of Liver Tumours; Nagy A. Habib (Faculty of Medicine) Book 2002 Kluwer Academic/Plenum Publishers, New York 200 [打印本頁] 作者: Ejaculation 時(shí)間: 2025-3-21 19:12
書目名稱Multi-Treatment Modalities of Liver Tumours影響因子(影響力)
書目名稱Multi-Treatment Modalities of Liver Tumours影響因子(影響力)學(xué)科排名
書目名稱Multi-Treatment Modalities of Liver Tumours網(wǎng)絡(luò)公開度
書目名稱Multi-Treatment Modalities of Liver Tumours網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Multi-Treatment Modalities of Liver Tumours被引頻次
書目名稱Multi-Treatment Modalities of Liver Tumours被引頻次學(xué)科排名
書目名稱Multi-Treatment Modalities of Liver Tumours年度引用
書目名稱Multi-Treatment Modalities of Liver Tumours年度引用學(xué)科排名
書目名稱Multi-Treatment Modalities of Liver Tumours讀者反饋
書目名稱Multi-Treatment Modalities of Liver Tumours讀者反饋學(xué)科排名
作者: Negligible 時(shí)間: 2025-3-21 21:14 作者: –DOX 時(shí)間: 2025-3-22 00:24 作者: cliche 時(shí)間: 2025-3-22 05:42
Book 2002fourth most common cause of death from cancer. Surgical resection of the tumour(s) is the treatment of choice and offers the only chance of prolonged survival. Yet the best attempts are often frustrated by either advanced or co-existent disease that renders the patient non-resectable. This book tack作者: delusion 時(shí)間: 2025-3-22 12:48 作者: Graves’-disease 時(shí)間: 2025-3-22 14:41
Book 2002survival. Yet the best attempts are often frustrated by either advanced or co-existent disease that renders the patient non-resectable. This book tackles the many options available to doctors and patients in an attempt to combat this desperate disease.作者: 聯(lián)合 時(shí)間: 2025-3-22 21:00 作者: Harridan 時(shí)間: 2025-3-22 21:38
8樓作者: byline 時(shí)間: 2025-3-23 01:21
9樓作者: degradation 時(shí)間: 2025-3-23 07:54
10樓作者: 排出 時(shí)間: 2025-3-23 09:48
第4樓作者: condemn 時(shí)間: 2025-3-23 17:51
第4樓作者: TOM 時(shí)間: 2025-3-23 20:20
5樓作者: MURAL 時(shí)間: 2025-3-24 00:30
5樓作者: 有斑點(diǎn) 時(shí)間: 2025-3-24 04:12
5樓作者: Entrancing 時(shí)間: 2025-3-24 08:28
5樓作者: debunk 時(shí)間: 2025-3-24 14:43
6樓作者: 忘川河 時(shí)間: 2025-3-24 18:20
6樓作者: 擺動(dòng) 時(shí)間: 2025-3-24 21:03
6樓作者: Organization 時(shí)間: 2025-3-24 23:11
6樓作者: Precursor 時(shí)間: 2025-3-25 03:19
7樓作者: 外向者 時(shí)間: 2025-3-25 10:50
7樓作者: scrutiny 時(shí)間: 2025-3-25 11:56
7樓作者: 時(shí)代 時(shí)間: 2025-3-25 17:05
7樓作者: 變態(tài) 時(shí)間: 2025-3-25 21:29
8樓作者: 熱烈的歡迎 時(shí)間: 2025-3-26 03:29
8樓作者: Fallibility 時(shí)間: 2025-3-26 04:30
8樓作者: 截?cái)?nbsp; 時(shí)間: 2025-3-26 10:54
8樓作者: 和平 時(shí)間: 2025-3-26 16:22
9樓作者: 結(jié)束 時(shí)間: 2025-3-26 18:39
9樓作者: Certainty 時(shí)間: 2025-3-26 21:47
9樓作者: declamation 時(shí)間: 2025-3-27 03:21
9樓作者: 不要不誠(chéng)實(shí) 時(shí)間: 2025-3-27 08:11
10樓作者: 細(xì)節(jié) 時(shí)間: 2025-3-27 12:02
10樓作者: COMMA 時(shí)間: 2025-3-27 14:43
10樓作者: 巫婆 時(shí)間: 2025-3-27 19:58
10樓
